Lymphoma News and Features
Young adult survivors of leukemia and lymphoma are more likely to report high stress compared with older survivors of the same diseases.
Findings compared to fine-needle aspiration cytology, especially for lymphoma, found that the sensitivity and negative predictive value for critical disease were significantly higher.
Pediatric patients with acute lymphoblastic leukemia (ALL) showed a 90% response rate from the first trials testing an investigational personalized cellular therapy known as CTL019.
Aerobic exercise may boost progression-free survival in patients with lymphoma, trial data suggests.
Patients with B-cell non-Hodgkin lymphomas and advanced solid tumors have responded to a new drug that is being tested for the first time in humans in a phase I clinical trial.
Peripheral T-cell lymphoma (PTCL) is a rare and aggressive form of cancer. This fact sheet explains the condition to newly diagnosed patients and provides sources of support.
- Women educated on overdiagnsosis are less likely to want mammogram
- New treatment method shrinks ovarian cancer tumors and improves chemotherapy effectiveness
- Epigenetic signatures differentiate triple negative breast cancers
- Novel drug approved for multiple myeloma
- New mechanism of acquired resistance to breast cancer drugs discovered
- Suicide deemed public health concern in those with genitourinary cancers
- New opportunity to treat drug-resistant leukemia discovered
- Major study links two new genetic variants to breast cancer
- Farydak (panobinostat) now FDA-approved for multiple myeloma
- Potential treatment for pancreatic cancer could increase life expectancy
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|